Tracie Oliver - Net Worth and Insider Trading

Tracie Oliver Net Worth

The estimated net worth of Tracie Oliver is at least $2 Million dollars as of 2025-04-29. Tracie Oliver is the Chief Commercial Officer of Arrowhead Pharmaceuticals Inc and owns about 127,107 shares of Arrowhead Pharmaceuticals Inc (ARWR) stock worth over $2 Million. Details can be seen in Tracie Oliver's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Tracie Oliver has not made any transactions after 2024-07-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Tracie Oliver

To

Tracie Oliver Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tracie Oliver owns 1 companies in total, including Arrowhead Pharmaceuticals Inc (ARWR) .

Click here to see the complete history of Tracie Oliver’s form 4 insider trades.

Insider Ownership Summary of Tracie Oliver

Ticker Company Transaction Date Type of Owner
ARWR Arrowhead Pharmaceuticals Inc 2024-07-02 Chief Commercial Officer

Tracie Oliver Latest Holdings Summary

Tracie Oliver currently owns a total of 1 stock. Tracie Oliver owns 127,107 shares of Arrowhead Pharmaceuticals Inc (ARWR) as of July 2, 2024, with a value of $2 Million.

Latest Holdings of Tracie Oliver

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARWR Arrowhead Pharmaceuticals Inc 2024-07-02 127,107 13.52 1,718,487

Holding Weightings of Tracie Oliver


Tracie Oliver Form 4 Trading Tracker

According to the SEC Form 4 filings, Tracie Oliver has made a total of 3 transactions in Arrowhead Pharmaceuticals Inc (ARWR) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Arrowhead Pharmaceuticals Inc is the sale of 9,394 shares on July 2, 2024, which brought Tracie Oliver around $237,480.

Insider Trading History of Tracie Oliver

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tracie Oliver Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Tracie Oliver Ownership Network

Ownership Network List of Tracie Oliver

No Data

Ownership Network Relation of Tracie Oliver

Insider Network Chart

Tracie Oliver Owned Company Details

What does Arrowhead Pharmaceuticals Inc do?

Who are the key executives at Arrowhead Pharmaceuticals Inc?

Tracie Oliver is the Chief Commercial Officer of Arrowhead Pharmaceuticals Inc. Other key executives at Arrowhead Pharmaceuticals Inc include director & President and CEO Christopher Richard Anzalone , General Counsel Patrick O'brien , and CFO Kenneth Allen Myszkowski .

Arrowhead Pharmaceuticals Inc (ARWR) Insider Trades Summary

Over the past 18 months, Tracie Oliver made 2 insider transaction in Arrowhead Pharmaceuticals Inc (ARWR) with a net sale of 9,468. Other recent insider transactions involving Arrowhead Pharmaceuticals Inc (ARWR) include a net sale of 622,793 shares made by Christopher Richard Anzalone , a net sale of 85,112 shares made by James C Hamilton , and a net sale of 101,271 shares made by Kenneth Allen Myszkowski .

In summary, during the past 3 months, insiders sold 492,547 shares of Arrowhead Pharmaceuticals Inc (ARWR) in total and bought 0 shares, with a net sale of 492,547 shares. During the past 18 months, 959,377 shares of Arrowhead Pharmaceuticals Inc (ARWR) were sold and 3,000 shares were bought by its insiders, resulting in a net sale of 956,377 shares.

Arrowhead Pharmaceuticals Inc (ARWR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arrowhead Pharmaceuticals Inc Insider Transactions

No Available Data

Tracie Oliver Mailing Address

Above is the net worth, insider trading, and ownership report for Tracie Oliver. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Tracie Oliver's mailing address is: Pasadena Ca 91105.